IceCure Medical Stock (NASDAQ:ICCM)
Previous Close
$0.67
52W Range
$0.54 - $1.53
50D Avg
$0.62
200D Avg
$0.83
Market Cap
$47.51M
Avg Vol (3M)
$277.79K
Beta
2.27
Div Yield
-
ICCM Company Profile
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.